These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15319752)

  • 1. [Cataract surgery and prostaglandin analogs? Yes, but under certain conditions].
    Cochereau I
    J Fr Ophtalmol; 2004 Jun; 27(6 Pt 2):706-7. PubMed ID: 15319752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandins and cystoid macular edema.
    Miyake K; Ibaraki N
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S203-18. PubMed ID: 12204717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost.
    Lima MC; Paranhos A; Salim S; Honkanen R; Devgan L; Wand M; Gaudio AR; Shields MB
    J Glaucoma; 2000 Aug; 9(4):317-21. PubMed ID: 10958605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension.
    Moroi SE; Gottfredsdottir MS; Schteingart MT; Elner SG; Lee CM; Schertzer RM; Abrams GW; Johnson MW
    Ophthalmology; 1999 May; 106(5):1024-9. PubMed ID: 10328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery.
    Altintaş O; Yüksel N; Karabaş VL; Demirci G
    Eur J Ophthalmol; 2005; 15(1):158-61. PubMed ID: 15751259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystoid macular edema in aphakia and pseudophakia after use of prostaglandin analogs.
    Halpern DL; Pasquale LR
    Semin Ophthalmol; 2002; 17(3-4):181-6. PubMed ID: 12759848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias.
    Miyake K; Ota I; Maekubo K; Ichihashi S; Miyake S
    Arch Ophthalmol; 1999 Jan; 117(1):34-40. PubMed ID: 9930158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudophakic cystoid macular oedema: 30 months after latanoprost challenge.
    Dhingra N; Morgan JE
    Eye (Lond); 2007 Feb; 21(2):269-71. PubMed ID: 16858440
    [No Abstract]   [Full Text] [Related]  

  • 9. CME and anterior uveitis with latanoprost use.
    Thorne JE; Maguire AM; Lanciano R
    Ophthalmology; 1998 Nov; 105(11):1981-3. PubMed ID: 9818590
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystoid macular edema associated with latanoprost use in a pseudophakic eye with a history of surgical complications.
    Watanabe K; Hayasaka S; Hayasaka Y; Nagaki Y; Watanabe K
    Jpn J Ophthalmol; 2003; 47(1):110-2. PubMed ID: 12586189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latanoprost and cystoid macular edema in high-risk aphakic or pseudophakic eyes.
    Wand M; Gaudio AR; Shields MB
    J Cataract Refract Surg; 2001 Sep; 27(9):1397-401. PubMed ID: 11566522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprost.
    Esquenazi S
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):567-70. PubMed ID: 18001244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystoid macular edema associated with latanoprost therapy in a pseudophakic vitrectomized patient after removal of silicone oil endotamponade.
    Jäger M; Jonas JB
    Eur J Ophthalmol; 2003 Mar; 13(2):221-2. PubMed ID: 12696646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost.
    Carrillo MM; Nicolela MT
    Am J Ophthalmol; 2004 May; 137(5):966-8. PubMed ID: 15126179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESCRS Binkhorst lecture 2002: Pseudophakic preservative maculopathy.
    Miyake K; Ibaraki N; Goto Y; Oogiya S; Ishigaki J; Ota I; Miyake S
    J Cataract Refract Surg; 2003 Sep; 29(9):1800-10. PubMed ID: 14522305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes.
    Ayyala RS; Cruz DA; Margo CE; Harman LE; Pautler SE; Misch DM; Mines JA; Richards DW
    Am J Ophthalmol; 1998 Oct; 126(4):602-4. PubMed ID: 9780112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients.
    Warwar RE; Bullock JD; Ballal D
    Ophthalmology; 1998 Feb; 105(2):263-8. PubMed ID: 9479285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latanoprost-associated cystoid macular edema.
    Callanan D; Fellman RL; Savage JA
    Am J Ophthalmol; 1998 Jul; 126(1):134-5. PubMed ID: 9683162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystoid macular edema in the era of ocular hypotensive lipids.
    Wand M; Shields BM
    Am J Ophthalmol; 2002 Mar; 133(3):393-7. PubMed ID: 11915838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.